Počet záznamov: 1
goserelín
SYS d017273 LBL 00000nz--a2200000o--4500 005 20250606214804.0 008 920519|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D06.472.699.327.740.320.340 065 $a D12.644.400.400.740.320.340 065 $a D12.644.456.460.315 065 $a D12.644.548.365.740.320.340 065 $a D12.776.631.650.405.740.320.340 066 $a 01 $c 03 150 $a goserelín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d018931 $Y Antineoplastic Agents, Hormonal $w P $a antineoplastiká hormonálne 665 $a 93; was ICI 118630 (NM) 1979-92 $2 eng 665 $a Buserelin/analogs & derivatives (1984-1992) $2 eng 665 $a Gonadorelin/analogs & derivatives (1979-1984) $2 eng 680 9-
$i A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer. $2 eng 750 -2
$a Goserelin $2 eng 980 $x M
Počet záznamov: 1